|
| Date |
Type |
Disease |
Title |
|
May 12, 2008 |
Abstract |
CFIDS&FM |
S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial [ISRCTN36233495] – Source: BMC Musculoskeletal Disorders, Feb 2004
The dietary supplement SAMe has a slower onset of action but supports improved comfort in knee osteoarthritis patients as effectively as the prescription NSAID drug celecoxib (brand name CelebrexR). [Source: BMC Musculoskeletal Disorders, Feb 2004] |
|
May 12, 2008 |
Article,Events |
CFIDS&FM |
June 22 & 23 in Baltimore, MD: International Symposium on Viruses in Chronic Fatigue Syndrome and Post-Viral Fatigue
Reporting the latest in viral/genomic research & treatment, 22 top names from 7 countries will convene in Baltimore June 22-23 - sponsored by the HHV-6 Foundation, the IACFS/ME, and others. |
|
May 09, 2008 |
Abstract |
CFIDS&FM |
Curcumin and cancer: An ‘old-age’ disease with an ‘age-old’ solution – Source: Cancer Letters, May 5, 2008
MD Anderson Cancer Center summarizes research indicating the potential benefits of curcumin to support the body’s defenses against various types of cancer (not to mention many other conditions, from arthritis and Alzheimer's to psoriasis). [Source: Cancer Letters, May 5, 2008] |
|
May 09, 2008 |
Abstract |
CFIDS&FM |
Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis – Source: Journal of Infectious Diseases, Apr 2008
More on the findings of Jonathan Kerr (St. George’s University of London), et al. regarding seven identified gene expression subtypes of ME/CFS patients – as reported at the May 6, 2008 International Conference on ME/CFS Biomedical Research. [Source: Journal of Infectious Diseases, Apr 2008] |
|
May 09, 2008 |
Abstract |
CFIDS&FM |
Assessment of pain: A community-based diary survey in the USA – Source: The Lancet, May 2008
National survey finds more than one-fourth of U.S. adults suffer daily pain; with some differences by economic status; calculates the national cost in lost productivity. [Source: The Lancet, May 2008] |
|
May 08, 2008 |
Abstract |
CFIDS&FM |
A Systematic Review of Chronic Fatigue Syndrome: Don’t Assume It’s Depression – Source: Primary Care Companion to the Journal of Clinical Psychiatry, #2, 2008
Evidence review concludes "ME/CFS is underdiagnosed in more than 80% of the people who have it; and at the same time is often misdiagnosed as depression." Evaluating and managing it is challenging for physicians, and it's a challenging and difficult condition for patients. A bio-psycho-social approach to evaluation & management is recommended. [Source: Primary Care Companion to the Journal of Clinical Psychiatry, #2, 2008] |
|
May 08, 2008 |
Abstract |
CFIDS&FM |
Role of central dopamine in pain and analgesia - Source: Expert Review of Neurotherapeutics, May 2008
Patrick B Wood's scientific update on the role of dopamine abnormalities/activity in central nervous system pain perception & pain relief for FM, Parkinson’s, RLS, etc. Continued research "may lead to the development of novel therapeutic strategies." [Source: Expert Review of Neurotherapeutics, May 2008] |
|
May 08, 2008 |
Abstract |
CFIDS&FM |
The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in Fibromyalgia syndrome and allied syndromes – Source: Joint, Bone, Spine, May 2, 2008
Researchers are understanding increasingly that disturbances in the brain's sleep-wake cycle are a significant factor in FM pain & fatigue - along with a focus on medications to address them. [Source: Joint, Bone, Spine, May 2, 2008] |
|
May 08, 2008 |
Article |
CFIDS&FM |
On-The-Fly Reports from the May 5 & 6 CFS Advisory Committee Meeting in Washington, DC, From PANDORA President Marly Silverman
The CFSAC makes presentations on behalf of the ME/CFS community to inform and advise the Secretary of HHS. You can go to Marly’s blog to share her informal daily reports on meeting highlights. |
|
May 07, 2008 |
Abstract |
CFIDS&FM |
Double-blind Placebo-Controlled Trial of Amitriptyline for the Treatment of Irritable Bowel Syndrome in Adolescents – Source: Journal of Pediatrics, May 2008
Though this drug comes with a black box warning for adolescents when used for depression, this small UCLA trial indicates a lower dose (already used in adult IBS treatment) offers promise for improved quality of life in adolescents with IBS. Long-term follow-up and investigation of alternatives is planned. [Source: Journal of Pediatrics, May 2008] |
|
|
Next 10 Articles>> |
|
|
|
